Eli Lilly has inked a deal worth up to $2.75 billion with AI pharma firm Insilico Medicine to develop and commercialize AI-discovered oral drugs globally.

Tsinghua and Peking Universities publish Nature study on FLEXI chip integrating 10,628 transistors with ultra-low 55.94 μW power consumption, achieving 99.2% arrhythmia detection accuracy for next-generation wearable health devices.

NHS England begins groundbreaking trial combining AI software and robotic technology to detect and diagnose lung cancer faster, with potential to diagnose weeks earlier.

NVIDIA and Eli Lilly have announced a landmark $1 billion partnership to create a co-innovation lab focused on using AI to revolutionize drug discovery and pharmaceutical manufacturing, aiming to drastically reduce development timelines.